Bio-Techne Corp
SWB:TE1

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
SWB:TE1
Watchlist
Price: 49.6 EUR 1.64%
Market Cap: €12.1B

Gross Margin

66.6%
Current
Declining
by 0.3%
vs 3-y average of 66.9%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
66.6%
=
Gross Profit
$809.6m
/
Revenue
$1.2B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
66.6%
=
Gross Profit
€809.6m
/
Revenue
$1.2B

Peer Comparison

Country Company Market Cap Gross
Margin
US
Bio-Techne Corp
NASDAQ:TECH
8.9B USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
190.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
145.4B USD
Loading...
CH
Lonza Group AG
SIX:LONN
36.4B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.9B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
33.3B USD
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
29.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
17.5B EUR
Loading...

Market Distribution

Higher than 76% of companies in the United States of America
Percentile
76th
Based on 12 729 companies
76th percentile
66.6%
Low
-24 813% — 28.9%
Typical Range
28.9% — 60.5%
High
60.5% — 10 905 714.3%
Distribution Statistics
the United States of America
Min -24 813%
30th Percentile 28.9%
Median 43%
70th Percentile 60.5%
Max 10 905 714.3%

Bio-Techne Corp
Glance View

Bio-Techne Corp. began its journey with a clear focus: to bridge the gap between biological research and practical applications, a mission that it continues to pursue with zeal. At its core, Bio-Techne operates as a pioneer in the production and distribution of biotechnology products, catering to the needs of the scientific community across the globe. The company specializes in providing essential tools for life sciences research, including proteins, antibodies, and reagents, empowering researchers to explore and innovate in fields ranging from cancer biology to neuroscience. These offerings are developed with meticulous care and a deep understanding of the scientific process, which positions Bio-Techne as a trusted ally to laboratories and research institutions worldwide. The financial heartbeat of Bio-Techne lies in its diverse portfolio, which extends into clinical diagnostics and genomics, segments that are critical in an era of personalized medicine and rapid technological advancement in healthcare. The company's revenue streams are robust, driven by a strategic blend of direct sales and collaborations with major pharmaceutical and biotech companies. Furthermore, Bio-Techne smartly leverages its acquisitions to fortify its market position, enhancing its capabilities and expanding its product lines. This agility and foresight not only enable Bio-Techne to sustain its growth trajectory but also to continually meet the ever-evolving demands of a fast-paced, innovation-driven industry.

TE1 Intrinsic Value
47.26 EUR
Overvaluation 5%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
66.6%
=
Gross Profit
$809.6m
/
Revenue
$1.2B
What is Bio-Techne Corp's current Gross Margin?

The current Gross Margin for Bio-Techne Corp is 66.6%, which is below its 3-year median of 66.9%.

How has Gross Margin changed over time?

Over the last 3 years, Bio-Techne Corp’s Gross Margin has decreased from 68.3% to 66.6%. During this period, it reached a low of 66.1% on Sep 30, 2024 and a high of 68.3% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett